Calendar · pharmadog

Sign In Subscribe

Week of Apr 13, 2026

23

04/17/2026recall91d agoBreeder’s Edge, Shelter’s Choice recall: Animal & Veterinary, Food & Beverages

Canine milk replacer

full page →fda recalls ↗

Apr 17, 2026approval91d agoSODIUM ACETATE — FDA approvalSODIUM ACETATE

Sponsor: EXTROVIS. Form: SOLUTION. Route: INTRAVENOUS

full page →SODIUM ACETATE →fda approvals ↗

Apr 17, 2026approval91d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval91d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval91d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval91d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval91d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: QUAGEN. Form: SYRUP. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

Apr 17, 2026approval91d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Apr 17, 2026approval91d agoCALCIPOTRIENE — FDA approvalPrasco LLC

Sponsor: GLENMARK SPECLT. Form: CREAM. Route: TOPICAL

full page →fda approvals ↗

Apr 17, 2026approval91d agoESOMEPRAZOLE MAGNESIUM — FDA approvalesomeprazole magnesium DR

Sponsor: MARKSANS PHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →esomeprazole magnesium DR →fda approvals ↗

Apr 17, 2026approval91d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 17, 2026approval91d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 17, 2026approval91d agoTETRACYCLINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals of New York LLC

Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 17, 2026approval91d agoTETRACYCLINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals of New York LLC

Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 17, 2026grant91d agoUNIVERSITY OF WASHINGTON — Mentoring patient-oriented research on point-of-care diagnostics for infectio...University of Washington

AI grant. $209,758. PI: Paul K Drain

full page →nih reporter ↗

Apr 17, 2026grant91d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Assessing multi-site feasibility of an integrated whole-body hyperthermia and...University of California San Francisco

AT grant. $601,259. PI: Ashley E. Mason

full page →nih reporter ↗

Apr 17, 2026grant91d agoUNIVERSITY OF SOUTH FLORIDA — Aligning Circuit-Directed Rehabilitation with HPA Axis for Improved TBI Recovery

NS grant. $568,920. PI: Theresa Currier Thomas

full page →nih reporter ↗

Apr 17, 2026grant91d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Disrupting the Peri-necrotic Engine of Immunosuppression in GlioblastomaNorthwestern University

CA grant. $496,357. PI: DANIEL J BRAT

full page →nih reporter ↗

Apr 17, 2026grant91d agoMASSACHUSETTS GENERAL HOSPITAL — Toolkit for Optimal Pain Management in the Emergency Department: A mind-body ...Massachusetts General Hospital

AT grant. $170,640. PI: Julia E. Hooker

full page →nih reporter ↗

Apr 17, 2026grant91d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Novel Pediatric TB Diagnostics using Host and Microbial Biomarkers

AI grant. $210,302. PI: William Evan Johnson

full page →nih reporter ↗

Apr 17, 2026grant91d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Remote Loading of Melanocortin and GLP-1 Peptides in Polymers for Treatment o...

DK grant. $231,000. PI: Roger D. Cone

full page →nih reporter ↗

Apr 17, 2026grant91d agoRESEARCH TRIANGLE INSTITUTE — Development of Neuromedin Receptor 2 antagonists as Novel Analgesics

NS grant. $230,562. PI: Thuy Nguyen

full page →nih reporter ↗

Apr 17, 2026grant91d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Analyzing the Distribution, Effectiveness, and Implementation of Wildfire Smo...University of California San Francisco

ES grant. $117,747. PI: Rebecca Sugrue

full page →nih reporter ↗

Week of Apr 20, 2026

5

04/20/2026recall88d agoAligned Medical Angio Pack recall: Medical Devices

Angio Packs (AMS6908E and AMS6908F)

full page →fda recalls ↗

Apr 20, 2026approval

Week of Apr 27, 2026

6

Apr 30, 2026filing78d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration

full page →ranibizumab biosimilar →source: globaldata

Apr 30, 2026filing

Date TBD

16

TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

full page →dexamethasone LA →fda approvals ↗

TBDapproval

← prev

page 1 of 87